ENHERTU® (fam-trastuzumab deruxtecan-nxki) Patient Website
ENHERTU is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and who have received a prior anti-HER2 breast cancer treatment:
HER2-positive mBC & ENHERTU® (fam-trastuzumab deruxtecan …
Find information about HER2-positive mBC, how ENHERTU® (fam-trastuzumab deruxtecan-nxki) is thought to work, and how you will receive it. See the full Important Safety Information, Prescribing Information, including Boxed WARNINGS, …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU is a prescription medicine used to treat adults who have: HER2-low breast cancer that cannot be removed by surgery or that has spread to other parts of your body (metastatic), and who have received a prior chemotherapy:
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Potential Side …
ENHERTU is given 1 time every three weeks (21-day treatment cycle). Your healthcare provider will decide how many treatments you need. Your healthcare provider will give you medicines before your infusion to help prevent nausea and vomiting.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Results with …
Understanding the ENHERTU® (fam-trastuzumab deruxtecan-nxki) clinical trial results. See the full Important Safety Information, Prescribing Information, including Boxed WARNINGS, and Medication Guide for more information.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | About ENHERTU
ENHERTU is a prescription medicine used to treat adults who have: HER2-low breast cancer that cannot be removed by surgery or that has spread to other parts of your body (metastatic), and who have received a prior chemotherapy:
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Patient Site
ENHERTU is a prescription medicine used to treat adults who have: Non-small cell lung cancer (NSCLC) that has a certain mutation in the HER2 gene and cannot be removed by surgery or has spread to other parts of your body (metastatic), and who have received a prior treatment.
ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Support and …
ENHERTU is given 1 time every three weeks (21-day treatment cycle). Your healthcare provider will decide how many treatments you need. Your healthcare provider will give you medicines before your infusion to help prevent nausea and vomiting.
- [PDF]
ENHERTU AND YOU
ENHERTU is a prescription medicine used to treat adults who have: • Solid tumors that are HER2-positive (IHC 3+) and that cannot be removed by surgery or have spread to other parts of your body (metastatic), and who have received a prior
What is ENHERTU? ENHERTU is a prescription medicine used in adults to treat human epidermal growth factor receptor 2 (HER2)-positive stomach cancer called gastric or gastroesophageal junction (GEJ) adenocarcinoma that has spread to areas near your stomach (locally advanced) or that has spread to other parts of your